TickerFactsScreenerDevelopers

GT Biopharma, Inc. (GTBP) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2010: -$5.47M2011: -$5.10M2012: -$6.34M2013: -$6.33M2014: -$29.57M2015: -$50.57M2016: -$18.92M2017: $251.69M2018: $11.37M2019: -$19.31M2020: -$29.43M2021: $21.91M2022: $11.73M2023: $7.48M2024: -$1.67M2025: $5.79M$5.79M
2010Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$5.79M+446.5%
2024-$1.67M-122.3%
2023$7.48M-36.3%
2022$11.73M-46.4%
2021$21.91M+174.4%
2020-$29.43M-52.4%
2019-$19.31M-269.8%
2018$11.37M-95.5%
2017$251.69M+1430.0%
2016-$18.92M+62.6%
2015-$50.57M-71.0%
2014-$29.57M-366.9%
2013-$6.33M+0.0%
2012-$6.34M-24.2%
2011-$5.10M+6.7%
2010-$5.47M—